Frequent epigenetic inactivation of <it>RASSF2 </it>in thyroid cancer and functional consequences

Frequent epigenetic inactivation of <it>RASSF2 </it>in thyroid cancer and functional consequences

<p>Abstract</p> <p>Background</p> <p>The Ras association domain family (RASSF) encodes for distinct tumor suppressors and several members are frequently silenced in human cancer. In our study, we analyzed the role of RASSF2, RASSF3, RASSF4, RASSF5A, RASSF5C and RASSF6 a...

Full description

Bibliographic Details
Main Authors:	Hornung Juliane, Richter Antje M, Schagdarsurengin Undraga, Lange Cornelia, Steinmann Katrin, Dammann Reinhard H
Format:	Article
Language:	English
Published:	BMC 2010-09-01
Series:	Molecular Cancer
Online Access:	http://www.molecular-cancer.com/content/9/1/264

Similar Items

The novel <it>RASSF6 </it>and <it>RASSF10 </it>candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
by: Maher Eamonn R, et al.
Published: (2009-07-01)

Epigenetically inactivated RASSF1A as a tumor biomarker
by: Dora Raos, et al.
Published: (2020-11-01)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
by: Djos Anna, et al.
Published: (2012-06-01)

Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
by: Antje M. Richter, et al.
Published: (2016-02-01)

ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
by: Antje M. Richter, et al.
Published: (2017-06-01)

Epigenetic Inactivation of the Tumor Suppressor <i>IRX1</i> Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis
by: Miriam M. Küster, et al.
Published: (2020-11-01)

RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer
by: Cheng Fan, et al.
Published: (2017-03-01)

Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma
by: Antje M. Richter, et al.
Published: (2013-11-01)

Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer
by: Reinhard H. Dammann, et al.
Published: (2017-10-01)

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
by: Encío Ignacio, et al.
Published: (2006-10-01)

The cellular functions of RASSF1A and its inactivation in prostate cancer
by: Karishma S Amin, et al.
Published: (2012-01-01)

The impact of autophagy in spermiogenesis
by: Nihan Ozturk, et al.
Published: (2017-01-01)

Claudin11 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin, but Uncommon in Nevus Cell Nevi
by: Sara K. Walesch, et al.
Published: (2015-07-01)

Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
by: C Christofer Juhlin, et al.
Published: (2010-03-01)

Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia.
by: Amaia Vilas-Zornoza, et al.
Published: (2011-02-01)

OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.
by: Yan Cui, et al.
Published: (2008-08-01)

Correction: Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation.
by: Yan Cui, et al.
Published: (2008-01-01)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
by: Hiroaki Iwasa, et al.
Published: (2015-12-01)

Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
by: Yan Cui, et al.
Published: (2008-01-01)

Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4
by: Undraga Schagdarsurengin, et al.
Published: (2017-10-01)

Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma
by: Yu Jing, et al.
Published: (2009-12-01)

RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis
by: Shou FY, et al.
Published: (2017-01-01)

Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
by: Ashutosh Kumar Arya, et al.
Published: (2017-06-01)

Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A.
by: Jer-Wei Chang, et al.
Published: (2010-01-01)

Time dependent of epigenetic effect of disulfiram on tumor suppressor gene of RASSF1A in Hela cancer cell line
by: Seyedeh naghme Noorirad, et al.
Published: (2018-03-01)

Epigenetic silencing of RASSF1A promotes tumourigenesis via alternative transcript expression, SFK activation and exosome secretion
by: Vlahov, Nikola Vitanov
Published: (2015)

Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients
by: Khushnuma Wahabi, et al.
Published: (2019-08-01)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
by: Natalia Volodko, et al.
Published: (2016-06-01)

Methylation-associated down-regulation of <it>RASSF1A </it>and up-regulation of <it>RASSF1C </it>in pancreatic endocrine tumors
by: Pelosi Giuseppe, et al.
Published: (2011-08-01)

The Role of RASSF1A Methylation in Cancer
by: Luke B. Hesson, et al.
Published: (2007-01-01)

Developmental functions of Drosophila ASPP and RASSF8
by: Zhou, Y.
Published: (2014)

Thyroid acropachy: Frequently overlooked finding
by: Manish Gutch, et al.
Published: (2014-01-01)

X Inactivation and Escape: Epigenetic and Structural Features
by: He Fang, et al.
Published: (2019-10-01)

PCDH18 is frequently inactivated by promoter methylation in colorectal cancer
by: Dan Zhou, et al.
Published: (2017-06-01)

Epigenetic inactivation of the autophagy–lysosomal system in appendix in Parkinson’s disease
by: Juozas Gordevicius, et al.
Published: (2021-08-01)

Epigenetic inactivation and aberrant transcription of <it>CSMD1 </it>in squamous cell carcinoma cell lines
by: Scholnick Steven B, et al.
Published: (2005-09-01)

RASSF1A Enhances Chemosensitivity of NSCLC Cells Through Activating Autophagy by Regulating MAP1S to Inactivate Keap1-Nrf2 Pathway
by: Wang J, et al.
Published: (2021-01-01)

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells
by: Maureen Keller, et al.
Published: (2019-04-01)

Frequent Hypermethylation of RASSF1A, TSLC1, High Viral Load of Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma, Matched Tumor-Adjacent Tissues
by: Liang Zhou, et al.
Published: (2005-09-01)

Epigenetic Inactivation of Protocadherin 10 by Methylation in Colorectal Cancer
by: Sahar Tavakolian, et al.
Published: (2020-02-01)

Cannot write session to /tmp/vufind_sessions/sess_to2ln84s9taf9lg1gg21jupvht